Nyrada Inc.
Nyrada Inc. (NYR.AX) Financial Performance & Income Statement Overview
Explore the financials of Nyrada Inc. (NYR.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Nyrada Inc. (NYR.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Nyrada Inc. NYR.AX financial performance.
Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
---|---|---|---|---|
Revenue | $797982.00 | $0.00 | $2.46M | $474468.00 |
Cost of Revenue | $1.81M | $2321.00 | $2841.00 | $3204.00 |
Gross Profit | -$1.01M | -$2321.00 | $2.45M | $471263.00 |
Gross Profit Ratio | -$1.27 | $0.00 | $1.00 | $0.99 |
R&D Expenses | $1.81M | $1.14M | $888654.00 | $4.24M |
SG&A Expenses | $1.55M | $1.12M | $1.41M | $1.17M |
Operating Expenses | $3.36M | $2.26M | $2.30M | $5.41M |
Total Costs & Expenses | $5.17M | $2.26M | $2.30M | $5.42M |
Interest Income | $0.00 | $0.00 | $0.00 | $148817.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $2076.00 | $2321.00 | $2841.00 | $3204.00 |
EBITDA | -$2.56M | -$2.36M | -$2.23M | -$5.69M |
EBITDA Ratio | -$3.21 | $0.00 | -$0.91 | -$11.41 |
Operating Income | -$4.37M | -$2.26M | -$2.30M | -$5.42M |
Operating Income Ratio | -$5.48 | $0.00 | -$0.94 | -$11.42 |
Other Income/Expenses (Net) | $1.11M | -$107227.00 | $65474.00 | -$280374.00 |
Income Before Tax | -$3.27M | -$2.36M | -$2.24M | -$5.70M |
Income Before Tax Ratio | -$4.10 | $0.00 | -$0.91 | -$12.008 |
Income Tax Expense | -$810533.00 | -$836344.00 | -$2.37M | -$543036.00 |
Net Income | -$2.46M | -$1.53M | $135299.00 | -$5.15M |
Net Income Ratio | -$3.08 | $0.00 | $0.06 | -$10.86 |
EPS | -$0.01 | -$0.009 | $0.001 | -$0.03 |
Diluted EPS | -$0.01 | -$0.009 | $0.001 | -$0.03 |
Weighted Avg Shares Outstanding | $190.50M | $162.36M | $156.009M | $156.009M |
Weighted Avg Shares Outstanding (Diluted) | $190.50M | $162.36M | $170.45M | $156.009M |
Over the last four quarters, Nyrada Inc. achieved steady financial progress, growing revenue from $474468.00 in Q4 2023 to $797982.00 in Q2 2025. Gross profit stayed firm with margins at -127% in Q2 2025 versus 99% in Q4 2023. Operating income totaled -$4.37M in Q2 2025, maintaining a -548% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$2.56M. Net income dropped to -$2.46M, with EPS at -$0.01. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan